1
МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ’Я УКРАЇНИ
ІВАНО-ФРАНКІВСЬКИЙ НАЦІОНАЛЬНИЙ МЕДИЧНИЙ УНІВЕРСИТЕТ
ТОВАРИСТВО МОЛОДИХ ВЧЕНИХ
СТУДЕНТСЬКЕ НАУКОВЕ ТОВАРИСТВО
ТЕЗИ ДОПОВІДЕЙ
92-ї науково-практичної конференції студентів та
молодих вчених із міжнародною участю
«ІННОВАЦІЇ В МЕДИЦИНІ ТА ФАРМАЦІЇ»
ABSTRACTS
o he 92 h Scien i ic Con e ence o S uden s and
Young Scien is s wi h In e na ional Pa icipa ion
«INNOVATIONS IN MEDICINE AND PHARMACY»
м. Івано-Франківськ, 2023
2
182
Тези доповідей 92-ї науково-практичної конференції студентів і молодих вчених «Інновації в медицині та фармації», 2023
Abs ac o he 92 h Scien i i c Con e ence o S uden s and Young Scien is s «Inno a ions in Medicine and Pha macy», 2023
Nige ia, 32.4% om Poland, and 40.5% om Uk aine. The su ey was anonymous and ca ied ou using a 20-ques ion ques ionnai e.
Resul s. I was es ablished ha a signi i can numbe o hose examined du ing he speci i ed pe iod a e su e ing om COVID-19 had
he ollowing symp oms: ches discom o (50%, 41.2%, and 53%), cough (60%, 50%, and 60%), sho ness o b ea h (30%, 33.3%, and
40%), inc eased blood glucose le els (0, 25% and 26.7%) in Nige ians, Poles, and Uk ainians, espec i ely. Responden s also indica ed
o he symp oms: headache, dizziness, gene al weakness, skin changes, and mani es a ions om he diges i e ac .
Conclusions.
1. Pos -co id synd ome is a mul idisciplina y p oblem ha equi es he a en ion o specialis s om di e en coun ies o he wo ld.
2. In o de o imp o e he quali y o li e, i is necessa y o pe sonalize ecommenda ions o ehabili a ion and ea men o complica ions
o each pa ien .
THE ASSOCIATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ATRIAL
FIBRILLATION: KEY INDICATORS OF THEIR CO-EXISTANCE
Teslenko O.B., Bielinskyi M.V., He ashchenko A.S.
Depa men o In e nal Medicine, Family and Eme gency Medicine
Depa men o In e nal Medicine №2 and Nu sing
I ano-F anki sk Na ional Medical Uni e si y
I ano-F anki sk, Uk aine, e-mail: [email p o ec ed]
In oduc ion. The p e alence o Nonalcoholic a y li e disease (NAFLD) and a ial i b illa ion (AF) has inc eased globally in ecen
yea s. Acco ding o ecen s udies, NAFLD and AF a ec app oxima ely 32% and 0.51% o he gene al popula ion espec i ely.
Aim. To in es iga e he associa ion be ween NAFLD and AF by u ilizing he Fib oTes -4 (FIB-4) and Nonalcoholic Fa y Li e Sco e
(NFS) indices and measu ing pe ios in le els.
Ma e ials and me hods. In his s udy, we en olled 96 pa ien s diagnosed wi h NAFLD ha a ended S a e Ins i u ion «Te i o ial
medical associa ion o he Minis y o In e nal A ai s o Uk aine in I ano-F anki sk egion» o in es iga e he associa ion be ween
NAFLD and AF. The s udy popula ion was di ided in o wo g oups: main g oup - 35 pa ien s wi h bo h NAFLD and AF, and con ol
g oup - 61 pa ien s wi h NAFLD only. Full blood coun was pe o med on HTI MICROCC-20PLUS. Biochemical es s we e pe o med
on HTI BioChem SA Semi-Au o Chemis y Analyze BC-3002-C-UA. All pa ien s had hei abdominal ul asound in es iga ion o
con i m NAFLD using he SonoScape S20. To assess li e i b osis he ollowing non-in asi e indices we e used: The Fib oTes -4 (FIB-4)
index and he Nonalcoholic Fa y Li e Sco e (NFS). Pe ios in was measu ed by ELISA me hod using he HTI ImmunoChem-2100, and
Human Pe ios in/OSF2 ELISA Ki PicoKine®. The s a is ical analysis o his s udy was conduc ed using IBM SPSS S a is ics e sion
26.0.
Resul s. The NAFLD + AF g oup also had highe le els o pe ios in (10.8 ± 1.6 ng/ml s. 9.8 ± 1.75 ng/ml, p <0.001) and highe
NFS (-1.05 ± 1.46 s. -2.65 ± 1.63. p <0.001) and FIB-4 sco e (1.34±0.86 s 1.07±0.6. p=0.048). Pe ios in was ound o associa e wi h
he isk o NAFLD + AF wi h an OR o 2.079 (95% CI: 1.418 – 3.048. p<0.001). Simila esul s we e wi h NFS (OR=3.233. 95% CI:
1.970 - 5.303. p<0.001) and FIB-4 (OR=2.498. 95% CI: 1.109 – 5.627. p=0.027). The ecei e ope a ing cha ac e is ic (ROC) analysis
was pe o med on h ee a iables, NFS, FIB-4 and pe ios in, o de e mine hei abili y o dis inguish be ween pa ien s wi h NAFLD + AF
and NAFLD only. The esul s showed ha NFS had he highes a ea unde he cu e (AUC) wi h a alue o 0.868 (95% CI: 0.792-0.943.
p<0.001), indica ing excellen disc imina o y abili y. FIB-4 had an AUC o 0.651 (95% CI: 0.537-0.765. p=0.014), while pe ios in had an
AUC o 0.759 (95% CI: 0.660-0.858. p<0.001).
Conclusions. These i ndings sugges a s ong associa ion be ween NAFLD and AF, and highligh s he impo ance o conside ing AF
as a po en ial complica ion in pa ien s wi h NAFLD. The use o he FIB-4 and NFS indices and measu emen o pe ios in le els p o ed
o be e ec i e in de ec ing his associa ion.
3
